Laboratory Medicine Associates 279 3 Ave STE 508, Long Branch, NJ 07740 (732)2298711 (phone), (732)2290245 (fax)
Monmouth Medical Center Pathology 300 2 Ave, Long Branch, NJ 07740 (732)9237356 (phone), (732)9237355 (fax)
Education:
Medical School Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China Graduated: 1984
Languages:
English
Description:
Dr. Kang graduated from the Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China in 1984. He works in Long Branch, NJ and 1 other location and specializes in Anatomic Pathology & Clinical Pathology. Dr. Kang is affiliated with Monmouth Medical Center.
Name / Title
Company / Classification
Phones & Addresses
Yong Kang Owner
Sushi Garden Eating Place
1680 Crystal Sq Arc, Arlington, VA 22202 (703)4135477
Yong Kang Director Of Pharmacy
Servants of Relief for Incurable Cancer, The, Inc Skilled Nursing Home for Incurable Cancer Patients
760 Pollard Blvd SW, Atlanta, GA 30315 (404)6889515
Yong J. Kang Chief Executive Officer, Chief Financial Officer
Misono Inc Eating Place
2500 Old Alabama Rd, Roswell, GA 30076 (770)9933056
Yong Kang Secretary
KOREAN AFRICAN-AMERICAN CULTURAL INSTITUTE, INC
1100 Peachtree St NE STE 2160, Atlanta, GA 159 Armour Dr NE, Atlanta, GA
Yong T Kang President, Director
KANGS, INC
2610 S Ferncreek Ave, Orlando, FL 32806
Yong Kang Principal
WIRELESSONE, INC Business Services at Non-Commercial Site · Nonclassifiable Establishments
Western is also home to research by Chil-Yong Kang, a scientist trying to develop the world's first vaccine for HIV. He's already shown his vaccine is safe and potentially effective in a clinical trial involving a few dozen people.
Date: Dec 01, 2014
Category: Health
Source: Google
First-Ever Preventative HIV Vaccine Trials Show No Adverse Effects
The vaccine is based on a genetically modified killed whole virus (SAV001-H), developed by Dr. Chil-Yong Kang and his team at the Schulich School of Medicine & Dentistry, with the support of Sumagen Canada. The vaccine holds tremendous promise for success in the final phases of clinical testing
for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection," said Dr. Chil-Yong Kang, a researcher and professor at Western's Schulich School of Medicine and Dentistry.